The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Erectile Dysfunction Treatment Market Research Report 2025
Synopsis
Erectile dysfunction (ED) also known as impotence, refers to problems with achieving and maintaining erections.Currently available treatment for erectile dysfunction is oral therapy, usually with pde-5 inhibitors (sildenafil, tadalafil, avanafil and vardenafil), as well as penis implants, vacuum contractile devices and shockwave therapy.
The global Erectile Dysfunction Treatment market was valued at US$ 4855 million in 2023 and is anticipated to reach US$ 6888.9 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction Treatment.
Report Scope
The Erectile Dysfunction Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Erectile Dysfunction Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erectile Dysfunction Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boston Scientific
Coloplast Group
Zephyr Surgical Implants
Medispec
Augusta Medical Systems
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
KARL STORZ
Dong-A ST
Metuchen Pharma
Seoul Pharma
Segment by Type
Oral Treatment
Penis Implant
Vacuum Shrinkage Device
Shock Wave Therapy
Segment by Application
Hospital
Specialist Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Erectile Dysfunction Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Erectile dysfunction (ED) also known as impotence, refers to problems with achieving and maintaining erections.Currently available treatment for erectile dysfunction is oral therapy, usually with pde-5 inhibitors (sildenafil, tadalafil, avanafil and vardenafil), as well as penis implants, vacuum contractile devices and shockwave therapy.
The global Erectile Dysfunction Treatment market was valued at US$ 4855 million in 2023 and is anticipated to reach US$ 6888.9 million by 2030, witnessing a CAGR of 5.2% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Erectile Dysfunction Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erectile Dysfunction Treatment.
Report Scope
The Erectile Dysfunction Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Erectile Dysfunction Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erectile Dysfunction Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boston Scientific
Coloplast Group
Zephyr Surgical Implants
Medispec
Augusta Medical Systems
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
KARL STORZ
Dong-A ST
Metuchen Pharma
Seoul Pharma
Segment by Type
Oral Treatment
Penis Implant
Vacuum Shrinkage Device
Shock Wave Therapy
Segment by Application
Hospital
Specialist Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Erectile Dysfunction Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Erectile Dysfunction Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Oral Treatment
1.2.3 Penis Implant
1.2.4 Vacuum Shrinkage Device
1.2.5 Shock Wave Therapy
1.3 Market by Application
1.3.1 Global Erectile Dysfunction Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Specialist Clinic
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Erectile Dysfunction Treatment Market Perspective (2019-2030)
2.2 Erectile Dysfunction Treatment Growth Trends by Region
2.2.1 Global Erectile Dysfunction Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Erectile Dysfunction Treatment Historic Market Size by Region (2019-2024)
2.2.3 Erectile Dysfunction Treatment Forecasted Market Size by Region (2025-2030)
2.3 Erectile Dysfunction Treatment Market Dynamics
2.3.1 Erectile Dysfunction Treatment Industry Trends
2.3.2 Erectile Dysfunction Treatment Market Drivers
2.3.3 Erectile Dysfunction Treatment Market Challenges
2.3.4 Erectile Dysfunction Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Erectile Dysfunction Treatment Players by Revenue
3.1.1 Global Top Erectile Dysfunction Treatment Players by Revenue (2019-2024)
3.1.2 Global Erectile Dysfunction Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Erectile Dysfunction Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Erectile Dysfunction Treatment Revenue
3.4 Global Erectile Dysfunction Treatment Market Concentration Ratio
3.4.1 Global Erectile Dysfunction Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Erectile Dysfunction Treatment Revenue in 2023
3.5 Erectile Dysfunction Treatment Key Players Head office and Area Served
3.6 Key Players Erectile Dysfunction Treatment Product Solution and Service
3.7 Date of Enter into Erectile Dysfunction Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Erectile Dysfunction Treatment Breakdown Data by Type
4.1 Global Erectile Dysfunction Treatment Historic Market Size by Type (2019-2024)
4.2 Global Erectile Dysfunction Treatment Forecasted Market Size by Type (2025-2030)
5 Erectile Dysfunction Treatment Breakdown Data by Application
5.1 Global Erectile Dysfunction Treatment Historic Market Size by Application (2019-2024)
5.2 Global Erectile Dysfunction Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Erectile Dysfunction Treatment Market Size (2019-2030)
6.2 North America Erectile Dysfunction Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Erectile Dysfunction Treatment Market Size by Country (2019-2024)
6.4 North America Erectile Dysfunction Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Erectile Dysfunction Treatment Market Size (2019-2030)
7.2 Europe Erectile Dysfunction Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Erectile Dysfunction Treatment Market Size by Country (2019-2024)
7.4 Europe Erectile Dysfunction Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Erectile Dysfunction Treatment Market Size (2019-2030)
8.2 Asia-Pacific Erectile Dysfunction Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Erectile Dysfunction Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Erectile Dysfunction Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Erectile Dysfunction Treatment Market Size (2019-2030)
9.2 Latin America Erectile Dysfunction Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Erectile Dysfunction Treatment Market Size by Country (2019-2024)
9.4 Latin America Erectile Dysfunction Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Erectile Dysfunction Treatment Market Size (2019-2030)
10.2 Middle East & Africa Erectile Dysfunction Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Erectile Dysfunction Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Erectile Dysfunction Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boston Scientific
11.1.1 Boston Scientific Company Detail
11.1.2 Boston Scientific Business Overview
11.1.3 Boston Scientific Erectile Dysfunction Treatment Introduction
11.1.4 Boston Scientific Revenue in Erectile Dysfunction Treatment Business (2019-2024)
11.1.5 Boston Scientific Recent Development
11.2 Coloplast Group
11.2.1 Coloplast Group Company Detail
11.2.2 Coloplast Group Business Overview
11.2.3 Coloplast Group Erectile Dysfunction Treatment Introduction
11.2.4 Coloplast Group Revenue in Erectile Dysfunction Treatment Business (2019-2024)
11.2.5 Coloplast Group Recent Development
11.3 Zephyr Surgical Implants
11.3.1 Zephyr Surgical Implants Company Detail
11.3.2 Zephyr Surgical Implants Business Overview
11.3.3 Zephyr Surgical Implants Erectile Dysfunction Treatment Introduction
11.3.4 Zephyr Surgical Implants Revenue in Erectile Dysfunction Treatment Business (2019-2024)
11.3.5 Zephyr Surgical Implants Recent Development
11.4 Medispec
11.4.1 Medispec Company Detail
11.4.2 Medispec Business Overview
11.4.3 Medispec Erectile Dysfunction Treatment Introduction
11.4.4 Medispec Revenue in Erectile Dysfunction Treatment Business (2019-2024)
11.4.5 Medispec Recent Development
11.5 Augusta Medical Systems
11.5.1 Augusta Medical Systems Company Detail
11.5.2 Augusta Medical Systems Business Overview
11.5.3 Augusta Medical Systems Erectile Dysfunction Treatment Introduction
11.5.4 Augusta Medical Systems Revenue in Erectile Dysfunction Treatment Business (2019-2024)
11.5.5 Augusta Medical Systems Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Detail
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Erectile Dysfunction Treatment Introduction
11.6.4 Eli Lilly Revenue in Erectile Dysfunction Treatment Business (2019-2024)
11.6.5 Eli Lilly Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Erectile Dysfunction Treatment Introduction
11.7.4 Pfizer Revenue in Erectile Dysfunction Treatment Business (2019-2024)
11.7.5 Pfizer Recent Development
11.8 Bayer
11.8.1 Bayer Company Detail
11.8.2 Bayer Business Overview
11.8.3 Bayer Erectile Dysfunction Treatment Introduction
11.8.4 Bayer Revenue in Erectile Dysfunction Treatment Business (2019-2024)
11.8.5 Bayer Recent Development
11.9 BaiYunShan General Factory
11.9.1 BaiYunShan General Factory Company Detail
11.9.2 BaiYunShan General Factory Business Overview
11.9.3 BaiYunShan General Factory Erectile Dysfunction Treatment Introduction
11.9.4 BaiYunShan General Factory Revenue in Erectile Dysfunction Treatment Business (2019-2024)
11.9.5 BaiYunShan General Factory Recent Development
11.10 S.K. Chemicals
11.10.1 S.K. Chemicals Company Detail
11.10.2 S.K. Chemicals Business Overview
11.10.3 S.K. Chemicals Erectile Dysfunction Treatment Introduction
11.10.4 S.K. Chemicals Revenue in Erectile Dysfunction Treatment Business (2019-2024)
11.10.5 S.K. Chemicals Recent Development
11.11 Teva Pharma
11.11.1 Teva Pharma Company Detail
11.11.2 Teva Pharma Business Overview
11.11.3 Teva Pharma Erectile Dysfunction Treatment Introduction
11.11.4 Teva Pharma Revenue in Erectile Dysfunction Treatment Business (2019-2024)
11.11.5 Teva Pharma Recent Development
11.12 KARL STORZ
11.12.1 KARL STORZ Company Detail
11.12.2 KARL STORZ Business Overview
11.12.3 KARL STORZ Erectile Dysfunction Treatment Introduction
11.12.4 KARL STORZ Revenue in Erectile Dysfunction Treatment Business (2019-2024)
11.12.5 KARL STORZ Recent Development
11.13 Dong-A ST
11.13.1 Dong-A ST Company Detail
11.13.2 Dong-A ST Business Overview
11.13.3 Dong-A ST Erectile Dysfunction Treatment Introduction
11.13.4 Dong-A ST Revenue in Erectile Dysfunction Treatment Business (2019-2024)
11.13.5 Dong-A ST Recent Development
11.14 Metuchen Pharma
11.14.1 Metuchen Pharma Company Detail
11.14.2 Metuchen Pharma Business Overview
11.14.3 Metuchen Pharma Erectile Dysfunction Treatment Introduction
11.14.4 Metuchen Pharma Revenue in Erectile Dysfunction Treatment Business (2019-2024)
11.14.5 Metuchen Pharma Recent Development
11.15 Seoul Pharma
11.15.1 Seoul Pharma Company Detail
11.15.2 Seoul Pharma Business Overview
11.15.3 Seoul Pharma Erectile Dysfunction Treatment Introduction
11.15.4 Seoul Pharma Revenue in Erectile Dysfunction Treatment Business (2019-2024)
11.15.5 Seoul Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
